Breckenridge Pharmaceutical, Inc recalls Alprazolam Tablets, USP, 0.25mg, CIV, packaged in: a) 100-count bottle (NDC 51991-0704-01), b) 500-count bottle and c) 1
Recalled March 22, 2023 · FDA recall D-0458-2023 · Breckenridge Pharmaceutical
Hazard
CGMP Deviations: Potential risk of Cross Contamination · FDA Class II
Units
N/A
Sold at
USA nationwide.
Description
CGMP Deviations: Potential risk of Cross Contamination
Product
Alprazolam Tablets, USP, 0.25mg, CIV, packaged in: a) 100-count bottle (NDC 51991-0704-01), b) 500-count bottle and c) 1,000-count bottle, Rx only, Manufactured by Centaur Pharmaceuticals PVT. LTD., Hinjewadi, Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037.
Manufacturer(s)
Breckenridge Pharmaceutical, Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →